Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Fai Ng

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|August 2, 2015
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsManuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's SyndromeG Nocturne, A Virone, Wan-Fai Ng, et al.
RMD Open|December 15, 2021
Genetic variants at the <i>RTP4/MASP1</i> locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndromeKatrine Brække Norheim, Juliana Imgenberg-Kreuz, Andrei Alexsson, et al.
RMD Open|November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndromePilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Frontiers in Neurology|July 12, 2023
Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunitiesAnna-Katharine Brem, Sajini Kuruppu, Casper de Boer, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Rheumatology (Oxford, England)|February 24, 2018
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activityIris L A Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|August 2, 2015
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsManuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2015
Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's SyndromeG Nocturne, A Virone, Wan-Fai Ng, et al.
RMD Open|December 15, 2021
Genetic variants at the <i>RTP4/MASP1</i> locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndromeKatrine Brække Norheim, Juliana Imgenberg-Kreuz, Andrei Alexsson, et al.
RMD Open|November 22, 2019
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndromePilar Brito-Zerón, Soledad Retamozo, Belchin Kostov, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphomaGaetane Nocturne, Jessica Tarn, Saida Boudaoud, et al.
Annals of the Rheumatic Diseases|September 1, 2023
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysisJoe Scott Berry, Jessica Tarn, John Casement, et al.
Frontiers in Neurology|July 12, 2023
Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunitiesAnna-Katharine Brem, Sajini Kuruppu, Casper de Boer, et al.
Rheumatology (Oxford, England)|December 17, 2020
The management of Sjögren's syndrome: British Society for Rheumatology guideline scopeElizabeth Price, Alexander Allen, Saaeha Rauz, et al.
Rheumatology (Oxford, England)|February 24, 2018
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activityIris L A Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, et al.
Pageof 14